While its growth was overshadowed in 2025 by A.I., the biotech sector grew signifcantly and 2026 looks for the trend to ...
StockStory.org on MSN
A look back at biotechnology stocks’ Q4 earnings: Incyte (NASDAQ:INCY) vs. the rest of the pack
Looking back on biotechnology stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Incyte ...
This little-known biotech could have a big hit on its hands with VK2735, a GLP-1 weight loss drug candidate.
The biotech sector is one that's become red-hot, at least in recent years. After around a decade of stagnation, investors appear to be intent on increasing their exposure to top biotech names in the ...
Adam Feuerstein, a senior writer and biotech columnist, is the author of Adam’s Biotech Scorecard, a subscriber-only ...
Learning how to trade biotech stocks offers some of the most explosive profit opportunities in the entire market—but also some of its most punishing risks. Biotech stocks can double or triple ...
Legend Biotech Corporation (NASDAQ:LEGN) is one of the best high growth healthcare stocks to buy now. RBC Capital cut the ...
IonQ is leading the way in quantum computing technology.
After several years of IPO drought in the biotech industry, the public market is picking up again. Will the trend keep going ...
Wave Life Sciences' shares dropped after its weight loss candidate failed to impress in a phase 1 study. However, this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results